SPL

2.22%

9.2¢ starpharma holdings limited

Ann: DEP irinotecan clinical data presented at AACR meeting, page-21

First 21 Last

Share
Profile

Follow
Teddyward

9,271 Posts.

833

17/10/23

18:55

Post #: 70392754
Share

Originally posted by Esmer: ↑

"Remember though the SP Floor will be $0.085 based off cash in bank."

LOL, there is no SP floor.

If a company looks like it will burn through all its cash without ever becoming profitable, it will eventually go belly-up, and the SP might go to zero long before. Holders will race to dump their shares before they become worthless, even if the company still has cash in the bank. Cash at bank is not available to shareholders. It is available for salaries and directors fees and other company expenses. Burn, baby, burn.

The reality is that several large holders are reducing their holdings. Presumably because of a significant possibility that SPL might never become profitable and might never become an attractive t/o target. With so many tens of millions of shares possibly earmarked for dumping, realistically the SP could be pushed down close to zero at any time.

The whole DEP thing looks increasingly like SPL is just a hobby pharma. Decades of of interesting projects, and always lots of negotiations, but never any substantial income. Progress is probably too slow to generate any significant revenue before the cash at bank runs out in a few years. In my opinion, if DEP was going to happen then it would have happened long ago. I will be very happy if SPL proves me wrong about this and gets some cash out of DEP.

I think that Viraleze offers some hope for shareholders. I think that the pending trial results will probably have a substantial impact on the SP, one way or the other. If the results are good, then for financial reasons I think that SPL needs to rearrange its priorities. And I think that the big shareholders need to put pressure on SPL to do this. Otherwise, many holders may regard even excellent results as immaterial and will try to get out on the spike.

Expand

I am not sure Viraleze will be the saviour if any of teh people involved in partner and distribution deals are at all involved . It has been poor at every level IMO. Still touting that it can be sold in so many countries but it is not selling!!!! People can't see why and refuse to see why and managment continue the speil IMO

SPL Price at posting: 13.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

Emerald & Azure score Digger & Dealer awards

EQR

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMD

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Bitcoin: Current State of Play & Where to Next | Swyftx

SVL

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

There are more pages in this discussion • 5 more messages in this thread...

First 21 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.2¢		Change 0.002(2.22%)		Mkt cap ! $37.93M

Open	High	Low	Value	Volume
9.2¢	9.3¢	9.2¢	$3.349K	36.18K

Buyers (Bids)

No.	Vol.	Price($)
2	113072	9.2¢

Sellers (Offers)

Price($)	Vol.	No.
9.3¢	108436	2

View Market Depth

No.	Vol.	Price($)
1	106072	0.092
2	161121	0.090
1	6000	0.089
1	127200	0.087
1	6395	0.086

Price($)	Vol.	No.
0.093	58436	1
0.099	1285	1
0.100	112106	4
0.105	19523	2
0.110	4000	1

Last trade - 16.10pm 16/08/2024 (20 minute delay)

SPL (ASX) Chart

Ann: DEP irinotecan clinical data presented at AACR meeting, page-21

Emerald & Azure score Digger & Dealer awards

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Bitcoin: Current State of Play & Where to Next | Swyftx

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: DEP irinotecan clinical data presented at AACR meeting, page-21

Top Stories

Emerald & Azure score Digger & Dealer awards

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Bitcoin: Current State of Play & Where to Next | Swyftx

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News